ArteraAI Stock
HealthTechLooking to sell ArteraAI stock or options?
Developer of AI-enabled predictive and prognostic cancer tests designed to identify patients who will benefit from therapy intensification. The company's tests leverage an algorithm that assesses digital images from a patient's biopsy and learns from a patient's clinical data, enabling clinicians with more information to make informed treatment decisions.
Notable investors include:
Other investors include:
Jeff Dean, Andrew Tan, Koch Disruptive Technologies, Dennis Wong, Rajiv Khemani, EnvisionX Capital, FactoryHQ, Wilson Sonsini Goodrich & Rosati, A&E Investments, Michael Driscoll.